Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 201.00
+6.20 (3.18%)
Nov 4, 2026, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 6.33 billion as of November 4, 2026. It is the 12,769th most valuable company in the world and the 169th biggest in Sweden. Its market cap has increased by 10.14% in one year.
Market Cap
6.33B
Enterprise Value
6.14B
Revenue
958.65M
Global Rank
Country Rank
#169 Sweden
PE Ratio
49.14
ChartMarket Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 6.33B, an increase of 1,603.40%. That is a compound annual growth rate of 22.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 6.33B | 7.72% |
| Dec 30, 2025 | 5.88B | -61.84% |
| Dec 30, 2024 | 15.40B | 48.41% |
| Dec 29, 2023 | 10.38B | 90.12% |
| Dec 30, 2022 | 5.46B | -33.55% |
| Dec 30, 2021 | 8.22B | -8.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 63.70B |
| Elekta AB | 23.47B |
| Vitrolife AB | 15.21B |
| Nolato AB | 13.93B |
| MedCap AB | 8.37B |
| CellaVision AB | 4.57B |
| BICO Group AB | 1.70B |
| Paxman AB | 1.48B |